<DOC>
	<DOCNO>NCT02573883</DOCNO>
	<brief_summary>This study do compare effect , good bad , radiofrequency laser treatment clobetasol proprionate .05 % ointment vulvar lichen sclerosus .</brief_summary>
	<brief_title>Clobetasol Proprionate Versus Radiofrequency CO2 Laser Treatment Lichen</brief_title>
	<detailed_description>Vulvar lichen sclerosus ( LS ) well-characterized dermatosis result labial atrophy , synechiae introital narrowing often cause dyspareunia , itch co-existent vulvar pain . Biopsy necessary confirm clinical diagnosis mainstay treatment usually consist topical steroid therapy ( Chi ) . Clobetasol proprionate mometasone furoate potent topical steroid long consider gold-standard treatment vulvar lichen sclerosus work anti-inflammatory , anti-mitotic , immunosuppressive effect . One complication long-term steroid use , however , potential thinning vulvar skin , therefore limit long-term use . Clobetasol proprionate range efficacy 61-91 % depend select outcome criterion . The vulvovaginal SmartXide -V2-LR laser system DEKA ( Calezano , Italy ) radiofrequency C02 laser maximum 40 Watt power laser energy emission 10,600 nanometer wavelength mainly absorb water underlie tissue ( Salvatore ) . The SmartXide-V2-LR system first introduced 2009 DOT therapy distributing fraction CO2 laser small spot 200 micron vulvar skin vaginal epithelium , result portion skin remain intact less tissue destruction faster healing ( Salvatore ) . The device clear US Food Drug Administration ( FDA ) incision , excision , ablation , coagulation gynecologic soft tissue . The fractioned therapy show stimulate fibroblastic growth activation biosynthesis collagen restoration extracelluar matrix collagen fiber . Very little know long-term effect C02 radiofrequency laser therapy use vulva vagina , although treatment widely accept plastic cosmetic surgery dermatology . Increased market laser vaginal rejuvenation spawn proprietary female genital cosmetic surgery industry US limit publish outcome data . SmartXide -V2-LR establish outcome data treatment genitourinary syndrome menopause GSM , also know vulvovaginal atrophy ( Salvatore ) . The purpose study compare safety efficacy clobetasol proprionate .05 % ointment radiofrequency CO2 laser procedure treatment vulvar lichen sclerosus . Women present urogynecology clinic screen lichen sclerosus . Vulvar biopsy perform confirmation , , eligible , patient consent undergo baseline questionnaire , photodocumentation vulvar lesion randomization . A minimum 2 week require time biopsy treatment . Patient randomize monthly LASER treatment 3 month topical STEROID therapy ( clobetasol propionate .05 % ointment nightly one month three time weekly 2 additional month ) 1:1 ratio use computer generate randomization schedule . Because nature treatment , possible blind patient assessor blind intervention . Patient questionnaire include multiple validated scale survey provide reproducible measure vulvar symptom primary secondary outcome . Questionnaires complete intake visit , repeat 12 week treatment complete 26-28 week intake , one year follow . The investigator expect improve subjective objective result LASER group 3 month compare STEROID group . Sample size calculation conduct use absolute change Skindex 29 primary end point . Out study reach 80 % power detect mean difference 16 point Skindex 29 ( sd=22 group ) study group 25 patient group , 50 total base one-sided two-sample t-test alpha=0.05 ( He ) . By account 10 % attrition , investigator propose recruit 56 patient study randomize 1:1 ratio group , block component use tropical clobetasol past . Data enter secure RedCAPS Database provide complete audit data management process . De-identified backup data keep locked file participate site . Plans publication handle investigator MedStar Washington Hospital Center adhere publication policy . All personnel access data collect complete Program Ethics Education Research train appropriate HIPAA certification .</detailed_description>
	<mesh_term>Lichen Sclerosus et Atrophicus</mesh_term>
	<mesh_term>Vulvar Lichen Sclerosus</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<criteria>Biopsy proven symptomatic vulvar lichen sclerosus Ability understand study , accept randomization logistically followup schedule visit English Speaking Known vulvar malignancy Pregnancy plan pregnancy le 3 month postpartum , premenapausal Current prior diagnosis gynecologic malignancy Previous pelvic radiation therapy Allergy topical steroid Active UTI , vulvar infection ( candida , herpes , bacterial vaginosis , trichomoniasis infection ) Pelvic organ prolapse &gt; Stage 2 Treatment systemic immunomodulators , topical calcineurin inhibitor ( tacrolimus , pimecrolimus ) , vaginal hormonal vulvar topical steroid use within 2 month enrollment History transvaginal mesh implant ( exclude sling sacrocolpopexy mesh ) IUD ( Intrauterine Device ) Skindex29 overall score &lt; 21 , mildly impaired health relate quality life threshold</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Vulva</keyword>
	<keyword>Lichen Sclerosus</keyword>
	<keyword>Radiofrequency Carbon Dioxide Laser</keyword>
	<keyword>Mona Lisa Laser</keyword>
	<keyword>Clobetasol Proprionate</keyword>
	<keyword>Vulvodynia</keyword>
</DOC>